Donaldson Inc Stock Price, News & Analysis

Donaldson Company (NYSE: DCI), a global leader in filtration products and solutions, announced that CFO Scott Robinson will present at the CL King 22nd Annual Best Ideas Conference on September 16, 2024, at 12:30 p.m. ET. The presentation will be available via live webcast on Donaldson's Investor Relations website, with replays accessible for approximately 90 days after the event.

Founded in 1915, Donaldson operates in over 140 locations across six continents, serving diverse industries through three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences. The company partners with customers ranging from small businesses to major OEM brands, providing innovative filtration solutions for complex challenges.

Donaldson Company (NYSE: DCI), a global leader in filtration products, has announced its participation in two upcoming investor conferences. Tod Carpenter, the company's chairman, president, and CEO, will present at:

1. The Jefferies Industrials Conference on September 5, 2024, at 1:55 p.m. ET
2. The Morgan Stanley 12th Annual Laguna Conference on September 11, 2024, at 3:15 p.m. ET

Live webcasts of both presentations will be available on Donaldson's Investor Relations website, with replays accessible for approximately 90 days afterward. Founded in 1915, Donaldson operates in over 140 locations across six continents, serving diverse industries through its Mobile Solutions, Industrial Solutions, and Life Sciences segments.

Donaldson Company (NYSE: DCI) reported record fourth quarter and fiscal year 2024 results:

• Q4 sales up 6.4% to $935 million
• Q4 GAAP EPS up 20% to $0.90; adjusted EPS up 20.5% to $0.94
• Full-year sales up 4.5% to $3.6 billion
• Full-year GAAP EPS up 16.6% to $3.38; adjusted EPS up 12.5% to $3.42

The company expects fiscal 2025 sales growth of 2-6% and adjusted EPS of $3.56-$3.72. Donaldson also updated its fiscal 2026 targets, forecasting 3-7% sales CAGR and 15.8-16.6% operating margin. The company plans to optimize its footprint for increased efficiency and returned $286 million to shareholders in fiscal 2024 through dividends and share repurchases.

Donaldson Company, Inc. (NYSE: DCI) has completed its acquisition of a 49% minority stake in Medica S.p.A., a leader in hollow fiber membrane filtration technology, for approximately €62 million. This strategic move aligns with Donaldson's goal of expanding its Life Sciences business. Medica, headquartered in Medolla, Italy, specializes in medical device applications and water purification. With over 700 employees globally, Medica generated €80 million in revenue in 2023. This acquisition is expected to enhance Donaldson's capabilities in the filtration industry and strengthen its position in the life sciences sector.

Donaldson Company, Inc. (NYSE: DCI), a global leader in filtration products and solutions, has announced its upcoming fourth quarter 2024 earnings conference call. The call will be webcast on Wednesday, August 28, 2024, at 9:00 a.m. CT. Investors can access the live webcast through the 'Events & Presentations' section of Donaldson's Investor Relations website. A replay will be available from approximately 12:00 p.m. CT on the same day.

Donaldson, founded in 1915, serves a wide range of industries and advanced markets through its three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences. The company operates in over 140 locations across six continents, partnering with diverse customers from small business owners to major OEM brands.

Donaldson Company, Inc. (NYSE: DCI), a global leader in filtration products and solutions, has announced a regular cash dividend of 27.0 cents per share. The dividend is payable on August 28, 2024, to shareholders of record on August 13, 2024. This declaration marks Donaldson's 68th consecutive year of quarterly cash dividends and its 28th consecutive year of annual dividend increases as of 2023. Donaldson is a member of the S&P High-Yield Dividend Aristocrats Index, reflecting its consistent dividend growth. The company, founded in 1915, operates through three primary segments: Mobile Solutions, Industrial Solutions, and Life Sciences, serving diverse industries and advanced markets globally.

Donaldson Company, Inc. (NYSE:DCI) has announced that DonorsChoose, an education equity organization, is the recipient of the Donaldson Foundation $100K Challenge grant. This year's theme focused on childhood education. The grant will be used to match donations made by the public for DonorsChoose projects in communities where Donaldson operates in the United States, effectively doubling the impact.

DonorsChoose was selected through a voting process involving Donaldson's U.S.-based employees. Two other finalists, Little Free Library and United Through Reading, will each receive $10,000 to support their missions. In fiscal year 2023, the Donaldson Foundation distributed $1.2 million to nonprofit organizations, emphasizing its commitment to supporting education initiatives and strengthening communities.

Donaldson's Univercells Technologies business has expanded its evaluation agreement with the Gene Therapy Program (GTP) at the University of Pennsylvania. The collaboration aims to assess the scalability of gene therapy production using Univercells Technologies' bioreactors, specifically the scale-X™ nitro 600 m2 bioreactor. This partnership seeks to increase production per batch and potentially reduce cost of goods sold (COGS) for gene therapies.

The agreement highlights the importance of industry-academic partnerships in advancing gene therapy development and commercialization. Univercells Technologies' bioreactor, initially developed with support from the Bill and Melinda Gates Foundation, is now being applied to enhance viral vector accessibility for gene therapies. This collaboration aligns with GTP's vision of making gene therapies for rare diseases more accessible worldwide.

Donaldson Company (NYSE: DCI), a leading global provider of filtration solutions, has announced key leadership changes effective August 1, 2024. Andrew Dahlgren, currently President of Life Sciences, will become President of Mobile Solutions. Richard Lewis, currently President of Mobile Solutions, will take over as President of Life Sciences. These changes support Donaldson's strategic initiatives and organizational development goals, aiming toward fiscal 2026 financial targets and 2030 sustainability ambitions. Both leaders, with extensive experience within the company, promise a seamless transition.